Terms: = Uterine cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Treatment
158 results:
1. FOXO3a deregulation in uterine smooth muscle tumors.
de Almeida TG; Ricci AR; Dos Anjos LG; Soares Junior JM; Maciel GAR; Baracat EC; Carvalho KC
Clinics (Sao Paulo); 2024; 79():100350. PubMed ID: 38636197
[TBL] [Abstract] [Full Text] [Related]
2. POTENTIAL LIFE PROGNOSTIC MARKER FOR MESENCHYMAL TUMOR RESEMBLING uterine LEIOMYOSARCOMA.
Nishikawa S; Hayashi T; Uzaki T; Yaegashi N; Abiko K; Konishi I
Georgian Med News; 2023 Oct; (343):119-126. PubMed ID: 38096528
[TBL] [Abstract] [Full Text] [Related]
3. Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma.
Hwang JR; Cho YJ; Ryu JY; Choi JY; Choi JJ; Sa JK; Kim HS; Lee JW
Biomed Pharmacother; 2023 Dec; 168():115792. PubMed ID: 37924789
[TBL] [Abstract] [Full Text] [Related]
4. Pseudoprogression in patients with uterine leiomyosarcoma treated with first-line single-agent doxorubicin.
Howroyd LR; Cornell I; Benson C; Napolitano A; Blackledge M; Sumhonmun T; Moskovic E; Kelly-Morland C; Adejolu M; Jones RL; Messiou C
Eur J Cancer; 2023 Oct; 192():113261. PubMed ID: 37604068
[TBL] [Abstract] [Full Text] [Related]
5. Unilateral ovarian recurrence 5 years after hysterectomy for microinvasive squamous cervical cancer stage IA1: a rare case report.
Tong L; Wu L
BMC Womens Health; 2023 Jul; 23(1):350. PubMed ID: 37393247
[TBL] [Abstract] [Full Text] [Related]
6. Epithelioid leiomyosarcoma: An unusual presentation.
Kalantri SH; Joseph LD; Priyathersini N; Elangovan B
J Cancer Res Ther; 2023; 19(2):490-492. PubMed ID: 37313923
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic factors, oncological treatment and outcomes of uterine sarcoma: 10 years' clinical experience from a tertiary care center in Pakistan.
Khan SR; Soomar SM; Asghari T; Ahmed A; Moosajee MS
BMC Cancer; 2023 Jun; 23(1):510. PubMed ID: 37277708
[TBL] [Abstract] [Full Text] [Related]
8. Downregulation of miR‑10b‑5p facilitates the proliferation of uterine leiomyosarcoma cells: A microRNA sequencing‑based approach.
Yoshida K; Yokoi A; Kitagawa M; Sugiyama M; Yamamoto T; Nakayama J; Yoshida H; Kato T; Kajiyama H; Yamamoto Y
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36929268
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.
Yang Z; Yang X; Liu X; Ma K; Meng YT; Yin HF; Wen J; Yang JH; Zhen Z; Feng ZH; Liao QP
BMC Cancer; 2023 Mar; 23(1):243. PubMed ID: 36918828
[TBL] [Abstract] [Full Text] [Related]
10. The biology and treatment of leiomyosarcomas.
Kerrison WGJ; Thway K; Jones RL; Huang PH
Crit Rev Oncol Hematol; 2023 Apr; 184():103955. PubMed ID: 36893945
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive immunohistochemical analysis based on the origin of leiomyosarcoma.
Bayçelebi D; Kefeli M; Yıldız L; Karagöz F
Pol J Pathol; 2022; 73(3):233-243. PubMed ID: 36734438
[TBL] [Abstract] [Full Text] [Related]
12. Epithelioid trophoblastic tumor: A case series.
Dash SS; Sakhadeo U; Karmarkar S; Mittal N; Menon S; Rekhi B; Deodhar KK
Indian J Pathol Microbiol; 2023; 66(1):148-151. PubMed ID: 36656227
[TBL] [Abstract] [Full Text] [Related]
13. HPV-positive cervical squamous cell carcinoma metastasis to the breast, mimicking primary tumor.
de Oliveira-Junior I; Barbin FF; Watanabe AHU; Dos Reis R; da Costa Vieira RA
Breast Dis; 2022; 41(1):407-411. PubMed ID: 36502298
[TBL] [Abstract] [Full Text] [Related]
14. Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma.
Harold J; Bellone S; Manavella DD; Mutlu L; McNamara B; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MS; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2023 Jan; 168():157-165. PubMed ID: 36442427
[TBL] [Abstract] [Full Text] [Related]
15. Long-read sequencing reveals oncogenic mechanism of HPV-human fusion transcripts in cervical cancer.
Liu M; Han Z; Zhi Y; Ruan Y; Cao G; Wang G; Xu X; Mu J; Kang J; Dai F; Wen X; Zhang Q; Li F
Transl Res; 2023 Mar; 253():80-94. PubMed ID: 36223881
[TBL] [Abstract] [Full Text] [Related]
16. Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study.
Wang F; Dai X; Chen H; Hu X; Wang Y
BMC Cancer; 2022 Oct; 22(1):1050. PubMed ID: 36207687
[TBL] [Abstract] [Full Text] [Related]
17. Clinical and Histopathological Predictors of Recurrence in uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers.
Borella F; Cosma S; Ferraioli D; Ray-Coquard I; Chopin N; Meeus P; Cockenpot V; Valabrega G; Scotto G; Turinetto M; Biglia N; Fuso L; Mariani L; Franchi D; Vidal Urbinati AM; Pino I; Bertschy G; Preti M; Benedetto C; Castellano I; Cassoni P; Bertero L
Ann Surg Oncol; 2022 Dec; 29(13):8302-8314. PubMed ID: 35976464
[TBL] [Abstract] [Full Text] [Related]
18. Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (lms-04): a randomised, multicentre, open-label phase 3 trial.
Pautier P; Italiano A; Piperno-Neumann S; Chevreau C; Penel N; Firmin N; Boudou-Rouquette P; Bertucci F; Balleyguier C; Lebrun-Ly V; Ray-Coquard I; Kalbacher E; Bardet A; Bompas E; Collard O; Isambert N; Guillemet C; Rios M; Archambaud B; Duffaud F;
Lancet Oncol; 2022 Aug; 23(8):1044-1054. PubMed ID: 35835135
[TBL] [Abstract] [Full Text] [Related]
19. [Clinicopathological features of mixed cervical carcinoma with adenoid cystic pattern].
Li LL; Cui YY; Gao PY; Xia L; Liu GZ; Liu H
Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):615-620. PubMed ID: 35785831
[No Abstract] [Full Text] [Related]
20. Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis.
Huss A; Klar M; Hasanov MF; Juhasz-Böss I; Bossart M
Arch Gynecol Obstet; 2023 Mar; 307(3):927-935. PubMed ID: 35780401
[TBL] [Abstract] [Full Text] [Related]
[Next]
